Hangzhou Haoyue Personal Care Co., Ltd (SHA:605009)
China · Delayed Price · Currency is CNY 22.62
-0.36 (-1.57%)
Oct 29, 2026, 3:00 PM CST
SHA:605009 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3,883 | 3,665 | 2,844 | 2,678 | 2,740 | 2,404 |
Other Revenue | 90.76 | 90.76 | 85.18 | 79.04 | 62.39 | 57.85 |
| 3,974 | 3,756 | 2,929 | 2,757 | 2,802 | 2,462 | |
Revenue Growth | 10.19% | 28.22% | 6.25% | -1.62% | 13.82% | -4.98% |
Cost of Revenue | 2,821 | 2,584 | 2,120 | 2,023 | 2,158 | 1,818 |
Gross Profit | 1,153 | 1,172 | 809.33 | 733.98 | 644.28 | 644 |
Selling, General & Admin | 722.25 | 754.74 | 287.53 | 202.32 | 155.2 | 138.79 |
Research & Development | 148.86 | 139.03 | 107.2 | 104.8 | 101.38 | 91.15 |
Other Operating Expenses | 15.57 | -4.7 | -14.17 | -5.91 | 5.43 | -4.7 |
Operating Expenses | 897.73 | 900.12 | 386.18 | 292.04 | 263.53 | 235.39 |
Operating Income | 255.32 | 271.53 | 423.15 | 441.93 | 380.75 | 408.61 |
Interest Expense | -15.21 | -15.21 | -15.86 | -13.18 | -5.56 | -5.96 |
Interest & Investment Income | 11.12 | 11.1 | 47.02 | 65.48 | 66.05 | 64.31 |
Currency Exchange Gain (Loss) | -1.06 | -1.06 | 7.43 | 1.24 | 0.9 | -1.3 |
Other Non Operating Income (Expenses) | 21.95 | -2.05 | -12.89 | -1.41 | -0.29 | 12.2 |
EBT Excluding Unusual Items | 272.13 | 264.31 | 448.85 | 494.07 | 441.85 | 477.86 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -51.24 |
Gain (Loss) on Sale of Assets | -1.78 | 0.45 | 5.02 | 3.01 | 0.21 | -1.05 |
Asset Writedown | -12.26 | -7.17 | -0.63 | -4.19 | - | -9.63 |
Other Unusual Items | 11.38 | 11.38 | 7.53 | 15.01 | 14.31 | - |
Pretax Income | 269.47 | 268.96 | 460.77 | 507.9 | 456.37 | 415.94 |
Income Tax Expense | 40.68 | 36.98 | 73.26 | 69.3 | 33.49 | 53.28 |
Net Income | 228.78 | 231.98 | 387.51 | 438.6 | 422.88 | 362.67 |
Net Income to Common | 228.78 | 231.98 | 387.51 | 438.6 | 422.88 | 362.67 |
Net Income Growth | -22.82% | -40.14% | -11.65% | 3.72% | 16.60% | -39.75% |
Shares Outstanding (Basic) | 216 | 215 | 215 | 216 | 220 | 223 |
Shares Outstanding (Diluted) | 216 | 215 | 215 | 216 | 220 | 223 |
Shares Change | 1.81% | -0.03% | -0.43% | -1.76% | -1.17% | 14.42% |
EPS (Basic) | 1.06 | 1.08 | 1.80 | 2.03 | 1.92 | 1.63 |
EPS (Diluted) | 1.06 | 1.08 | 1.80 | 2.03 | 1.92 | 1.63 |
EPS Growth | -24.19% | -40.12% | -11.27% | 5.58% | 17.98% | -47.34% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 87.83 | -324.66 | -63.83 | 502.4 | 190.07 | 356.9 |
Free Cash Flow Per Share | 0.41 | -1.51 | -0.30 | 2.32 | 0.86 | 1.60 |
Dividend Per Share | 0.850 | 0.850 | 1.214 | 1.214 | 0.536 | 0.714 |
Dividend Growth | 39.99% | -30.00% | 0% | 126.68% | -25.00% | 49.00% |
Gross Margin | 29.01% | 31.20% | 27.63% | 26.62% | 22.99% | 26.16% |
Operating Margin | 6.42% | 7.23% | 14.45% | 16.03% | 13.59% | 16.60% |
Profit Margin | 5.76% | 6.18% | 13.23% | 15.91% | 15.09% | 14.73% |
Free Cash Flow Margin | 2.21% | -8.64% | -2.18% | 18.22% | 6.78% | 14.50% |
EBITDA | 460.95 | 442.56 | 548.07 | 564.6 | 465.94 | 480.8 |
EBITDA Margin | 11.60% | 11.78% | 18.71% | 20.48% | 16.63% | 19.53% |
D&A For EBITDA | 205.63 | 171.04 | 124.91 | 122.67 | 85.19 | 72.19 |
EBIT | 255.32 | 271.53 | 423.15 | 441.93 | 380.75 | 408.61 |
EBIT Margin | 6.42% | 7.23% | 14.45% | 16.03% | 13.59% | 16.60% |
Effective Tax Rate | 15.10% | 13.75% | 15.90% | 13.64% | 7.34% | 12.81% |
Revenue as Reported | 3,756 | 3,756 | 2,929 | 2,757 | 2,802 | 2,462 |
Advertising Expenses | - | - | - | 83.35 | 48.56 | 38.72 |